Silver Book Fact

Death rates from heart disease and stroke are falling in-part because of new drug treatments. According to the National Heart, Lung and Blood Institute, if death rates were the same as those 30 years ago, 815,000 more Americans would die of heart disease annually and 250,000 more would die of stroke.

PhRMA. 2009 Report: Medicines in development for heart disease and stroke. Washington, D.C.: PhRMA; 2009. http://www.phrma.org/sites/default/files/653/heart_2009

Reference

Title
2009 Report: Medicines in development for heart disease and stroke
Publisher
PhRMA
Publication Date
2009
Authors
PhRMA
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A recent data analysis of more than 2,700 stroke patients from the U.S. and Europe confirmed tPA’s effectiveness, which could save the U.S. nearly $50 million a year.  
  • Between 1988 & 1994 and 1999 & 2004, use of pharmacological lipid-lowering treatment increased from 11.7% to 40.8%. Low-density lipoprotein cholesterol control increased from 4.0% to 25.1% among those with high…  
  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.  
  • In 2001, 86,000 more premature deaths from cardiovascular disease (50,000 men and 36,000 women) would have occurred among Americans age 40 and older without antihypertensive drug therapy.  
  • Pioglitazone associated with relative risk reduction in recurrent stroke
    The PROactive trial to manage glucose in diabetics with a history of cardiovascular disease, stroke, or other vascular risk factors found that treatment with pioglitazone was associated with a 47% relative…